{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:30:07Z","timestamp":1792812607744,"version":"4.5.0"},"reference-count":36,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0591-3","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T16:06:26Z","timestamp":1556035586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia"],"prefix":"10.1136","volume":"7","author":[{"given":"Marjolaine","family":"Debant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Hemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Buscaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinhinane","family":"Fali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Melayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelig","family":"Le Goux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vandier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Potier-Cartereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Olivier","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Tempescul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Berthou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bagacean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mignen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-5002","authenticated-orcid":false,"given":"Yves","family":"Renaudineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"591_CR1","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","volume":"3","author":"TJ Kipps","year":"2017","unstructured":"Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017;3:16096.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"591_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1182\/blood-2011-12-397158","volume":"120","author":"C Roy Le","year":"2012","unstructured":"Le Roy C, Deglesne PA, Chevallier N, Beitar T, Eclache V, Quettier M, et al. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia. Blood. 2012;120(2):356\u201365.","journal-title":"Blood."},{"issue":"6","key":"591_CR3","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.4049\/jimmunol.174.6.3749","volume":"174","author":"S Nedellec","year":"2005","unstructured":"Nedellec S, Renaudineau Y, Bordron A, Berthou C, Porakishvili N, Lydyard PM, et al. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients. J Immunol. 2005;174(6):3749\u201356.","journal-title":"J Immunol"},{"issue":"1","key":"591_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1600-065X.2009.00813.x","volume":"231","author":"Y Baba","year":"2009","unstructured":"Baba Y, Kurosaki T. Physiological function and molecular basis of STIM1-mediated calcium entry in immune cells. Immunol Rev. 2009;231(1):174\u201388.","journal-title":"Immunol Rev"},{"issue":"9","key":"591_CR5","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nri2152","volume":"7","author":"S Feske","year":"2007","unstructured":"Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol. 2007;7(9):690\u2013702.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"591_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/acs.jcim.6b00475","volume":"57","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Karolak A, Debant M, Buscaglia P, Renaudineau Y, Mignen O, et al. Molecular dynamics simulations of membrane-bound STIM1 to investigate conformational changes during STIM1 activation upon calcium release. J Chem Inf Model. 2017;57(2):335\u201344.","journal-title":"J Chem Inf Model"},{"issue":"4","key":"591_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.immuni.2017.09.003","volume":"47","author":"M Vaeth","year":"2017","unstructured":"Vaeth M, Maus M, Klein-Hessling S, Freinkman E, Yang J, Eckstein M, et al. Store-operated Ca2+ entry controls clonal expansion of T cells through metabolic reprogramming. Immunity. 2017;47(4):664\u201379 e6.","journal-title":"Immunity."},{"issue":"6","key":"591_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.immuni.2016.04.013","volume":"44","author":"M Vaeth","year":"2016","unstructured":"Vaeth M, Eckstein M, Shaw PJ, Kozhaya L, Yang J, Berberich-Siebelt F, et al. Store-operated ca(2+) entry in follicular T cells controls humoral immune responses and autoimmunity. Immunity. 2016;44(6):1350\u201364.","journal-title":"Immunity."},{"issue":"7\u20139","key":"591_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1387\/ijdb.150204om","volume":"59","author":"M Debant","year":"2015","unstructured":"Debant M, Hemon P, Brigaudeau C, Renaudineau Y, Mignen O. Calcium signaling and cell fate: how can Ca2+ signals contribute to wrong decisions for chronic lymphocytic leukemic B lymphocyte outcome? Int J Dev Biol. 2015;59(7\u20139):379\u201389.","journal-title":"Int J Dev Biol"},{"key":"591_CR10","doi-asserted-by":"publisher","unstructured":"Hemon P, Renaudineau Y, Debant M, Le Goux N, Mukherjee S, Brooks W, et al. Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity. Clin Rev Allergy Immunol. 2017;53(2):141\u201365. \n                    https:\/\/doi.org\/10.1007\/s12016-017-8607-6\n                    \n                  . Review. PubMed PMID: 28500564.","DOI":"10.1007\/s12016-017-8607-6"},{"key":"591_CR11","first-page":"143","volume":"393","author":"Y Baba","year":"2016","unstructured":"Baba Y, Kurosaki T. Role of calcium signaling in B cell activation and biology. Curr Top Microbiol Immunol. 2016;393:143\u201374.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"15\u201316","key":"591_CR12","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.molimm.2011.05.006","volume":"48","author":"Y Yarkoni","year":"2011","unstructured":"Yarkoni Y, Cambier JC. Differential STIM1 expression in T and B cell subsets suggests a role in determining antigen receptor signal amplitude. Mol Immunol. 2011;48(15\u201316):1851\u20138.","journal-title":"Mol Immunol"},{"issue":"6","key":"591_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1182\/blood-2016-03-707786","volume":"128","author":"A D'Avola","year":"2016","unstructured":"D'Avola A, Drennan S, Tracy I, Henderson I, Chiecchio L, Larrayoz M, et al. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL. Blood. 2016;128(6):816\u201326.","journal-title":"Blood."},{"issue":"2","key":"591_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/leu.2014.188","volume":"29","author":"AF Muggen","year":"2015","unstructured":"Muggen AF, Pillai SY, Kil LP, van Zelm MC, van Dongen JJ, Hendriks RW, et al. Basal ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia. Leukemia. 2015;29(2):321\u20138.","journal-title":"Leukemia."},{"issue":"7415","key":"591_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M Duhren-von Minden","year":"2012","unstructured":"Duhren-von Minden M, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309\u201312.","journal-title":"Nature."},{"issue":"10","key":"591_CR16","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2010-09-307405","volume":"117","author":"F Zhong","year":"2011","unstructured":"Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB, De Smedt H, et al. Induction of ca(2)+\u2212driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood. 2011;117(10):2924\u201334.","journal-title":"Blood."},{"key":"591_CR17","doi-asserted-by":"publisher","unstructured":"Garaud S, Taher TE, Debant M, Burgos M, Melayah S, Berthou C, et al. CD5 expression promotes IL-10 production through activation of the MAPK\/Erk pathway and upregulation of TRPC1 channels in B lymphocytes. Cell Mol Immunol. 2018;15(2):158-170. \n                    https:\/\/doi.org\/10.1038\/cmi.2016.42\n                    \n                  . Epub 2016 Aug 8. PubMed PMID: 27499044; PubMed Central PMCID:PMC5811677.","DOI":"10.1038\/cmi.2016.42"},{"issue":"2","key":"591_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/leu.2014.207","volume":"29","author":"T Vaisitti","year":"2015","unstructured":"Vaisitti T, Audrito V, Serra S, Buonincontri R, Sociali G, Mannino E, et al. The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. Leukemia. 2015;29(2):356\u201368.","journal-title":"Leukemia."},{"key":"591_CR19","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. OMS ed. Tumours WCo, editor 2008:"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OTT.S115892","volume":"10","author":"C Bagacean","year":"2017","unstructured":"Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M. Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report. Onco Targets Ther. 2017;10:31\u20134.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"591_CR21","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.4049\/jimmunol.1003050","volume":"186","author":"S Garaud","year":"2011","unstructured":"Garaud S, Morva A, Lemoine S, Hillion S, Bordron A, Pers JO, et al. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. J Immunol. 2011;186(8):4835\u201344.","journal-title":"J Immunol"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13148-017-0422-7","volume":"9","author":"C Bagacean","year":"2017","unstructured":"Bagacean C, Le Dantec C, Berthou C, Tempescul A, Saad H, Bordron A, et al. Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion. Clin Epigenetics. 2017;9:122.","journal-title":"Clin Epigenetics"},{"issue":"15","key":"591_CR23","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1158\/0008-5472.CAN-12-4572","volume":"73","author":"A Chantome","year":"2013","unstructured":"Chantome A, Potier-Cartereau M, Clarysse L, Fromont G, Marionneau-Lambot S, Gueguinou M, et al. Pivotal role of the lipid raft SK3-Orai1 complex in human cancer cell migration and bone metastases. Cancer Res. 2013;73(15):4852\u201361.","journal-title":"Cancer Res"},{"issue":"1","key":"591_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0167-4838(02)00211-X","volume":"1596","author":"RT Williams","year":"2002","unstructured":"Williams RT, Senior PV, Van Stekelenburg L, Layton JE, Smith PJ, Dziadek MA. Stromal interaction molecule 1 (STIM1), a transmembrane protein with growth suppressor activity, contains an extracellular SAM domain modified by N-linked glycosylation. Biochim Biophys Acta. 2002;1596(1):131\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"591_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ceca.2007.01.012","volume":"42","author":"TJ Shuttleworth","year":"2007","unstructured":"Shuttleworth TJ, Thompson JL, Mignen O. STIM1 and the noncapacitative ARC channels. Cell Calcium. 2007;42(2):183\u201391.","journal-title":"Cell Calcium"},{"issue":"Pt 3","key":"591_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1113\/jphysiol.2006.122432","volume":"579","author":"O Mignen","year":"2007","unstructured":"Mignen O, Thompson JL, Shuttleworth TJ. STIM1 regulates Ca2+ entry via arachidonate-regulated Ca2+\u2212selective (ARC) channels without store depletion or translocation to the plasma membrane. J Physiol. 2007;579(Pt 3):703\u201315.","journal-title":"J Physiol"},{"issue":"20","key":"591_CR27","first-page":"4493","volume":"57","author":"S Sabbioni","year":"1997","unstructured":"Sabbioni S, Barbanti-Brodano G, Croce CM, Negrini M. GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Res. 1997;57(20):4493\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"591_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1083\/jcb.134.3.771","volume":"134","author":"K Oritani","year":"1996","unstructured":"Oritani K, Kincade PW. Identification of stromal cell products that interact with pre-B cells. J Cell Biol. 1996;134(3):771\u201382.","journal-title":"J Cell Biol"},{"issue":"10","key":"591_CR29","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.bbamcr.2009.07.003","volume":"1793","author":"I Jardin","year":"2009","unstructured":"Jardin I, Lopez JJ, Redondo PC, Salido GM, Rosado JA. Store-operated Ca2+ entry is sensitive to the extracellular Ca2+ concentration through plasma membrane STIM1. Biochim Biophys Acta. 2009;1793(10):1614\u201322.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"591_CR30","doi-asserted-by":"publisher","first-page":"e1001025","DOI":"10.1371\/journal.pbio.1001025","volume":"9","author":"KT Cheng","year":"2011","unstructured":"Cheng KT, Liu X, Ong HL, Swaim W, Ambudkar IS. Local ca(2)+ entry via Orai1 regulates plasma membrane recruitment of TRPC1 and controls cytosolic ca(2)+ signals required for specific cell functions. PLoS Biol. 2011;9(3):e1001025.","journal-title":"PLoS Biol"},{"issue":"3\u20134","key":"591_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000015341","volume":"86","author":"S Sabbioni","year":"1999","unstructured":"Sabbioni S, Veronese A, Trubia M, Taramelli R, Barbanti-Brodano G, Croce CM, et al. Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD. Cytogenet Cell Genet. 1999;86(3\u20134):214\u20138.","journal-title":"Cytogenet Cell Genet"},{"issue":"37","key":"591_CR32","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1038\/onc.2014.404","volume":"34","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Liu X, Feng B, Liu N, Wu Q, Han Y, et al. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer. Oncogene. 2015;34(37):4808\u201320.","journal-title":"Oncogene."},{"issue":"1","key":"591_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0167-4838(00)00105-9","volume":"1481","author":"SS Manji","year":"2000","unstructured":"Manji SS, Parker NJ, Williams RT, van Stekelenburg L, Pearson RB, Dziadek M, et al. STIM1: a novel phosphoprotein located at the cell surface. Biochim Biophys Acta. 2000;1481(1):147\u201355.","journal-title":"Biochim Biophys Acta"},{"issue":"60","key":"591_CR34","doi-asserted-by":"publisher","first-page":"31590","DOI":"10.18632\/oncotarget.25657","volume":"9","author":"A Bordron","year":"2018","unstructured":"Bordron A, Bagacean C, Mohr A, Tempescul A, Bendaoud B, Deshayes S, et al. Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy. Oncotarget. 2018;9(60):31590\u2013605.","journal-title":"Oncotarget."},{"issue":"5","key":"591_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2217\/imt-2015-0015","volume":"8","author":"C Bagacean","year":"2016","unstructured":"Bagacean C, Zdrenghea M, Tempescul A, Cristea V, Renaudineau Y. Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises. Immunotherapy. 2016;8(5):569\u201381.","journal-title":"Immunotherapy."},{"issue":"9","key":"591_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.24826","volume":"92","author":"M Hallek","year":"2017","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2017;92(9):946\u201365.","journal-title":"Am J Hematol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-019-0591-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:44:11Z","timestamp":1601055851000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0591-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0591-3","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Board at the Brest University Hospital (OFICE, November 26th, 2015; clinicaltrials: NCT03294980) in accordance with the declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"111"}}